MedTrace Logo

Impact of Pharmaceutical Interviews Regarding the Management of Adverse Effects Related to the Antibiotic Therapy Used to Treat Osteoarticular Infections During Return Home

NCT05248490 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2024-12-04

No results posted yet for this study

Summary

The primary objective is to evaluate the impact of Pharmaceutical Interviews in the patient self-management of non-severe side effects caused by antibiotics prescribed for the treatment of osteoarticular infections when the patient returns home.

Conditions

  • Bone and Joint Infection

Interventions

OTHER

pharmaceutical interview

Pharmaceutical interview with pharmacist: to be informed treatment taken and related SAE informations at the end of hospitalization

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Thomas Tritz, PharmD · Pharmacy of Ambroise-Paré hospital, APHP

  • Christophe Menigaux, MD · Orthopedic surgery department, Ambroise Paré hospital, APHP

  • Nathalie Dournon, MD · Infectiology mobile team, Ambroise Paré hospital, APHP

  • Jessica Berdougo Berdougo, PharmD · Pitié-Salepetrière hospital, APHP

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-22
Primary Completion
2024-06-05
Completion
2024-06-14

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05248490 on ClinicalTrials.gov